Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results
MORGAN, Gareth J, DAVIES, Faith E, DRAYSON, Mark T, OWEN, Roger G, ROSS, Fiona M, RUSSELL, Nigel H, JACKSON, Graham H, CHILD, J. Anthony, GREGORY, Walter M, BELL, Sue E, SZUBERT, Alexander J, NAVARRO COY, Nuria, COOK, Gordon, FEYLER, Sylvia, JOHNSON, Peter R. E, RUDIN, Claudius
Published in Haematologica (Roma) (01.03.2012)
Published in Haematologica (Roma) (01.03.2012)
Get full text
Journal Article
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study
FEYLER, S, PRINCE, H. M, COOK, G, PEARCE, R, TOWLSON, K, NIVISON-SMITH, I, SCHEY, S, GIBSON, J, PATTON, N, BRADSTOCK, K, MARKS, D. I
Published in Bone marrow transplantation (Basingstoke) (01.09.2007)
Published in Bone marrow transplantation (Basingstoke) (01.09.2007)
Get full text
Journal Article
Analysis of current state and prospects of steel production development
Protopopov, E V, Feyler, S V
Published in IOP conference series. Materials Science and Engineering (01.09.2016)
Published in IOP conference series. Materials Science and Engineering (01.09.2016)
Get full text
Journal Article
Guidelines for supportive care in multiple myeloma 2011
Snowden, John A., Ahmedzai, Sam H., Ashcroft, John, D’Sa, Shirley, Littlewood, Timothy, Low, Eric, Lucraft, Helen, Maclean, Rhona, Feyler, Sylvia, Pratt, Guy, Bird, Jennifer M.
Published in British journal of haematology (01.07.2011)
Published in British journal of haematology (01.07.2011)
Get full text
Journal Article
Are there benefits to long-term bisphosphonate treatment in multiple myeloma (MM)? Insights from temporal analyses of zoledronic acid (ZOL) versus clodronate (CLO) in the MRC Myeloma IX Trial
Davies, F., Morgan, G., Wu, P., Gregory, W., Bell, S. E., Szubert, A., Navarro Coy, N., Drayson, M., Owen, R. G., Feyler, S., Ashcroft, J., Ross, F., Byrne, J., Roddie, H., Rudin, C., Cook, G., Jackson, G. H., Boyd, K., Child, J. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Does zoledronic acid (ZOL) reduce skeletal-related events (SREs) and improve progression-free survival (PFS) in patients (Pts) with multiple myeloma (MM) with or without bone disease? MRC myeloma IX study results
Boyd, K., Morgan, G., Davies, F., Wu, P., Gregory, W., Bell, S. E., Szubert, A., Navarro Coy, N., Drayson, M., Owen, R. G., Feyler, S., Ashcroft, J., Ross, F., Byrne, J., Roddie, H., Rudin, C., Cook, G., Jackson, G. H., Child, J. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Defining the biological subgroup of multiple myeloma patients which benefits maximally from the overall survival (OS) benefit associated with treatment with zoledronic acid (ZOL)
Morgan, G. J., Davies, F., Gregory, W., Bell, S. E., Szubert, A., Navarro Coy, N., Drayson, M., Owen, R. G., Feyler, S., Ashcroft, J., Ross, F., Byrne, J., Roddie, H., Rudin, C., Cook, G., Jackson, G. H., Boyd, K., Child, J. A., Wu, P.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
B325 Immune Dysregulation in MGUS: Evidence that MGUS Is Not an Immunologically Inert State
Feyler, S, Eccles, K, Rawstron, A, Owen, RG, von Lilienfeld-Toan, M, Jarmin, SJ, Ahcroft, J, Cook, G
Published in Clinical lymphoma & myeloma (01.02.2009)
Published in Clinical lymphoma & myeloma (01.02.2009)
Get full text
Journal Article